[1] |
Xu, S.C.; Tang, L.; Li, X.Z.; Fan, F.; Liu, Z.X. Immunotherapy for glioma: current management and future application. Cancer Lett. 2020, 476, 1–12.
|
[2] |
Ostrom, Q.T.; Gittleman, H.; Stetson, L.; Virk, S.; Barnholtz-Sloan, J.S. Epidemiology of Intracranial Gliomas. Prog. Neurol. Surg. 2018, 30, 1–11.
|
[3] |
Li, W.J.; Peng, X.N.; Wang, Z.Y.; Zhang, H.W.; Huang, H.B.; Liu, H.M.; Cai, L. The long noncoding RNA, growth arrest-specific 5, suppresses gastric cancer by downregulating miR-21 expression. Pharmacology. 2020, 105, 434–444.
|
[4] |
Shan, Y.T.; Huang, Y.B.; Lee, A.M.; Mentzer, J.; Ling, A.; Huang, R.S. A long noncoding RNA, GAS5 can be a biomarker for docetaxel response in castration resistant prostate cancer. Front. Oncol. 2021, 11, 675215.
|
[5] |
Mo, R.B.; Li, J.; Chen, Y.X.; Ding, Y.P. lncRNA GAS5 promotes pyroptosis in COPD by functioning as a ceRNA to regulate the miR‑223‑3p/NLRP3 axis. Mol. Med. Rep. 2022, 26, 219.
|
[6] |
Xu, W.; Zhang, L.; Geng, Y.; Liu, Y.; Zhang, N. Long noncoding RNA GAS5 promotes microglial inflammatory response in Parkinson’s disease by regulating NLRP3 pathway through sponging miR-223-3p. Int. Immunopharmacol. 2020, 85, 106614.
|
[7] |
Zhang, H.X.; Li, Y.Y.; Liu, Z.J.; Wang, J.F. Quercetin effectively improves LPS-induced intestinal inflammation, pyroptosis, and disruption of the barrier function through the TLR4/NF-κB/NLRP3 signaling pathway in vivo and in vitro. Food Nutr. Res. 2022, 66.
|
[8] |
Xie, W.K.; Chu, M.; Song, G.D.; Zuo, Z.Y.; Han, Z.; Chen, C.B.; Li, Y.Y.; Wang, Z.W. Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer. Semin. Cancer Biol. 2022, 83, 303–318.
|
[9] |
Liu, L.; Meng, T.; Yang, X.H.; Sayim, P.; Lei, C.; Jin, B.; Ge, L.; Wang, H.J. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion. Cancer Biomark. 2018, 22, 283–299.
|
[10] |
Filippova, E.A.; Fridman, M.V.; Burdennyy, A.M.; Loginov, V.I.; Pronina, I.V.; Lukina, S.S.; Dmitriev, A.A.; Braga, E.A. Long noncoding RNA GAS5 in breast cancer: epigenetic mechanisms and biological functions. Int. J. Mol. Sci. 2021, 22, 6810.
|
[11] |
Lin, G.H.; Wu, T.Z.; Gao, X.; He, Z.Q.; Nong, W.W. Research progress of long non-coding RNA GAS5 in malignant tumors. Front. Oncol. 2022, 12, 846497.
|
[12] |
Gu, J.A.; Wang, Y.P.; Wang, X.D.; Zhou, D.P.; Wang, X.G.; Zhou, M.; He, Z.M. Effect of the LncRNA GAS5-MiR-23a-ATG3 axis in regulating autophagy in patients with breast cancer. Cell Physiol. Biochem. 2018, 48, 194–207.
|
[13] |
Cheng, K.W.; Zhao, Z.G.; Wang, G.H.; Wang, J.A.; Zhu, W.M. lncRNA GAS5 inhibits colorectal cancer cell proliferation via the miR‑182‑5p/FOXO3a axis. Oncol. Rep. 2018, 2371–2380.
|
[14] |
Li, Y.H.; Gu, J.J.; Lu, H. The GAS5/miR-222 axis regulates proliferation of gastric cancer cells through the PTEN/akt/mTOR pathway. Dig. Dis. Sci. 2017, 62, 3426–3437.
|
[15] |
Braga, E.A.; Fridman, M.V.; Moscovtsev, A.A.; Filippova, E.A.; Dmitriev, A.A.; Kushlinskii, N.E. LncRNAs in ovarian cancer progression, metastasis, and main pathways: ceRNA and alternative mechanisms. Int. J. Mol. Sci. 2020, 21, 8855.
|
[16] |
Pandey, G.K.; Kanduri, C. Long non-coding RNAs: tools for understanding and targeting cancer pathways. Cancers. 2022, 14, 4760.
|
[17] |
Dang, Y.A.; Wei, X.D.; Xue, L.E.; Wen, F.L.; Gu, J.J.; Zheng, H.P. Long non-coding RNA in glioma: target miRNA and signaling pathways. Clin. Lab. 2018, 6, 887–894.
|
[18] |
Wang, C.; Tan, C.L.; Wen, Y.A.; Zhang, D.Z.; Li, G.F.; Chang, L.A.; Su, J.; Wang, X. FOXP1-induced lncRNA CLRN1-AS1 acts as a tumor suppressor in pituitary prolactinoma by repressing the autophagy via inactivating Wnt/β-catenin signaling pathway. Cell Death Dis. 2019, 10, 499.
|
[19] |
Xu, D.K.; Wang, L. The involvement of miRNAs in pituitary adenomas pathogenesis and the clinical implications. Eur. Neurol. 2022, 85, 171–176.
|
[20] |
Lu, M.R.; Gong, B.R.; Wang, Y.; Li, J.Y. CircBNC2 affects epithelial ovarian cancer progression through the miR-223-3p/LARP4 axis. Anti. Cancer Drugs. 2022, 34, 384–394.
|
[21] |
Wang, Z.Y.; Zhang, C.; Guo, J.; Wang, W.; Si, Q.; Chen, C.; Luo, Y.P.; Duan, Z.J. Exosomal miRNA-223-3p derived from tumor associated macrophages promotes pulmonary metastasis of breast cancer 4T1 cells. Transl. Oncol. 2023, 35, 101715.
|
[22] |
Jin, L.; Jiang, D.C.; Chen, H.X.; Liu, S.; Chen, Z.L.; Ju, J. Quercetin reverses adriamycin resistance in breast cancer by regulating GSK-3β/β-catenin via GAS5. Chin. Clin. Pharm. Ther. 2021, 12, 1344–1351.
|
[23] |
Wang, Y.B.; Yin, B.; Li, D.N.; Wang, G.J.; Han, X.D.; Sun, X.J. GSDME mediates caspase-3-dependent pyroptosis in gastric cancer. Biochem. Biophys. Res. Commun. 2018, 495, 1418–1425.
|
[24] |
Zhu, S.; Zhang, Z.; Jia, L.Q.; Zhan, K.X.; Wang, L.J.; Song, N.; Liu, Y.; Cheng, Y.Y.; Yang, Y.J.; Guan, L.; Min, D.Y.; Yang, G.L. Valproic acid attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-pyroptosis pathways. Neurochem. Int. 2019, 124, 141–151.
|
[25] |
Kelley, N.; Jeltema, D.; Duan, Y.H.; He, Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int. J. Mol. Sci. 2019, 20, 3328.
|